Parkinsonism: Difference between revisions
Content deleted Content added
→Etiology: removed self-link |
|||
| Line 27: | Line 27: | ||
==Etiology== |
==Etiology== |
||
If Parkinson's disease has been excluded, the [[differential diagnosis]] or list of potential causes for Parkinsonism syndrome includes: |
If Parkinson's disease has been excluded, the [[differential diagnosis]] or list of potential causes for Parkinsonism syndrome includes: |
||
* [[AIDS]] can sometimes lead to the symptoms of |
* [[AIDS]] can sometimes lead to the symptoms of secondary parkinsonism, due to commonly causing dopaminergic dysfunction. Indeed Parkinsonism can be a presenting feature of HIV infection.<ref>{{cite journal | author = Tse W | title = Movement disorders and AIDS: a review | journal = Parkinsonism Relat. Disord. | volume = 10 | issue = 6 | pages = 323–34 | year = 2004 | pmid = 15261874 | doi = 10.1016/j.parkreldis.2004.03.001 | author-separator = , | author2 = Cersosimo MG | author3 = Gracies JM | display-authors = 3 | last4 = Morgello | first4 = S | last5 = Olanow | first5 = CW | last6 = Koller | first6 = W}}</ref> |
||
* [[Corticobasal degeneration]]<ref name=Aminoff_2005/> |
* [[Corticobasal degeneration]]<ref name=Aminoff_2005/> |
||
* [[Creutzfeldt-Jakob disease]]<ref>{{cite journal | author = Maltête D, Guyant-Maréchal L, Mihout B, Hannequin D | title = Movement disorders and Creutzfeldt-Jakob disease: a review | journal = Parkinsonism Relat. Disord. | volume = 12 | issue = 2 | pages = 65–71 | year = 2006 | pmid = 16364674 | doi = 10.1016/j.parkreldis.2005.10.004}}</ref> |
* [[Creutzfeldt-Jakob disease]]<ref>{{cite journal | author = Maltête D, Guyant-Maréchal L, Mihout B, Hannequin D | title = Movement disorders and Creutzfeldt-Jakob disease: a review | journal = Parkinsonism Relat. Disord. | volume = 12 | issue = 2 | pages = 65–71 | year = 2006 | pmid = 16364674 | doi = 10.1016/j.parkreldis.2005.10.004}}</ref> |
||
Revision as of 22:04, 26 December 2012
| Parkinsonism | |
|---|---|
| Specialty | Neurology  |
Parkinsonism (also known as Parkinson's syndrome, atypical Parkinson's, or secondary Parkinson's) is a neurological syndrome characterized by tremor, hypokinesia, rigidity, and postural instability.[1] The underlying causes of parkinsonism are numerous, and diagnosis can be complex.[2] While the neurodegenerative condition Parkinson's disease (PD) is the most common cause of parkinsonism, a wide-range of other etiologies may lead to a similar set of symptoms, including some toxins, a few metabolic diseases, and a handful of non-PD neurological conditions.[3] Its most common cause is as a side effect of medications, mainly neuroleptic antipsychotics especially the phenothiazines (such as perphenazine and chlorpromazine), thioxanthenes (such as flupenthixol and zuclopenthixol) and butyrophenones (such as haloperidol (Haldol)), piperazines (such as ziprasidone), and, rarely, antidepressants.[citation needed]
Etiology
If Parkinson's disease has been excluded, the differential diagnosis or list of potential causes for Parkinsonism syndrome includes:
- AIDS can sometimes lead to the symptoms of secondary parkinsonism, due to commonly causing dopaminergic dysfunction. Indeed Parkinsonism can be a presenting feature of HIV infection.[4]
- Corticobasal degeneration[1]
- Creutzfeldt-Jakob disease[5]
- Dementia pugilistica or "boxer's dementia" is a condition that occurs in boxers due to chronic brain trauma
- Diffuse Lewy body disease[1]
- Drug-induced parkinsonism ("pseudoparkinsonism") due to drugs such as antipsychotics, metoclopramide, MPTP[6][1]
- Encephalitis lethargica[1]
- Multiple system atrophy[7]
- Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome)[8]
- Progressive supranuclear palsy[1]
- Toxicity due to substances such as carbon monoxide,[9] carbon disulfide,[9] manganese,[9] paraquat,[10] mercury,[11] hexane, rotenone, and toluene [citation needed]
- Vascular parkinsonism[12]
- Wilson's disease is a genetic disorder in which there is an abnormal accumulation of copper. The excess copper can lead to the formation of a copper-dopamine complex, which leads to the oxidation of dopamine to aminochrome.[13] The most common manifestations include: bradykinesia, cogwheel rigidity and a lack of balance. [14]
- Paraneoplastic syndrome. Neurological symptoms caused by antibodies associated with various cancers
- Neurodegeneration with brain iron accumulation (NBIA), A.K.A. Hallervorden-Spatz disease[15]
- Genetic
- Rapid onset dystonia parkinsonism (DYT12)
- Parkin mutation
- X-linked dystonia parkinsonism (DYT3)
- Autosomal recessive juvenile parkinsonism (ARJP)
References
- ^ a b c d e f Aminoff MJ, Greenberg DA, Simon RP (2005). Clinical Neurology (6th ed.). Lange: McGraw-Hill Medical. pp. 241–5. ISBN 0-07-142360-5.
{{cite book}}: CS1 maint: multiple names: authors list (link) - ^ Tuite PJ, Krawczewski K (2007). "Parkinsonism: a review-of-systems approach to diagnosis". Seminars in neurology. 27 (2): 113–22. doi:10.1055/s-2007-971174. PMID 17390256.
- ^ Christine CW, Aminoff MJ (2004). "Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance". Am. J. Med. 117 (6): 412–9. doi:10.1016/j.amjmed.2004.03.032. PMID 15380498.
- ^ Tse W; Cersosimo MG; Gracies JM; et al. (2004). "Movement disorders and AIDS: a review". Parkinsonism Relat. Disord. 10 (6): 323–34. doi:10.1016/j.parkreldis.2004.03.001. PMID 15261874.
{{cite journal}}: Unknown parameter|author-separator=ignored (help) - ^ Maltête D, Guyant-Maréchal L, Mihout B, Hannequin D (2006). "Movement disorders and Creutzfeldt-Jakob disease: a review". Parkinsonism Relat. Disord. 12 (2): 65–71. doi:10.1016/j.parkreldis.2005.10.004. PMID 16364674.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Watanabe Y, Himeda T, Araki T (2005). "Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease" (PDF). Med. Sci. Monit. 11 (1): RA17–23. PMID 15614202.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Wenning GK, Geser F (2003). "Multiple system atrophy". Rev. Neurol. (Paris). 159 (5 Pt 2): 3S31–8. PMID 12773886.
- ^ Uc EY, Rodnitzky RL (2003). "Childhood dystonia". Seminars in pediatric neurology. 10 (1): 52–61. doi:10.1016/S1071-9091(02)00010-4. PMID 12785748.
- ^ a b c DeLong MR, Juncos JL (2004). Parkinson's Disease and Other Movement Disorders. In: Harrison's Principles of Internal Medicine (16th ed.). McGraw-Hill Professional. p. 2414. ISBN 0-07-140235-7.
- ^ Dinis-Oliveira RJ; Remião F; Carmo H; et al. (2006). "Paraquat exposure as an etiological factor of Parkinson's disease". Neurotoxicology. 27 (6): 1110–22. doi:10.1016/j.neuro.2006.05.012. PMID 16815551.
{{cite journal}}: Unknown parameter|author-separator=ignored (help) - ^ Tremor/InvoluntaryMovements: Excerpt from Field Guide to Bedside Diagnosis
- ^ Thanvi B, Lo N, Robinson T (2005). "Vascular Parkinsonism--an important cause of parkinsonism in older people" (PDF). Age and ageing. 34 (2): 114–9. doi:10.1093/ageing/afi025. PMID 15713855.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ Członkowska A; Tarnacka B; Möller JC; et al. (2007). "Unified Wilson's Disease Rating Scale — a proposal for the neurological scoring of Wilson's disease patients". Neurol. Neurochir. Pol. 41 (1): 1–12. PMID 17330175.
{{cite journal}}: Unknown parameter|author-separator=ignored (help) - ^ Lorincz MT (2010). "Neurologic Wilson's disease". Ann. N. Y. Acad. Sci. 1184: 173–87. doi:10.1111/j.1749-6632.2009.05109.x. PMID 20146697.
{{cite journal}}: Unknown parameter|month=ignored (help) - ^ Online Mendelian Inheritance in Man (OMIM): NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1 - 234200